Secretin-stimulated MR cholangio-pancreatography in the evaluation of asymptomatic patients with non-specific pancreatic hyperenzymemia

European Journal of Radiology

Volumn 75, Issue 2, 2010, Pages

  Donati, Francescamaria ^a   Boraschi, Piero ^a   Gigoni, Roberto ^a   Salemi, Simonetta ^a   Faggioni, Lorenzo ^b   Bertucci, Cristina ^b   Cecchi, Claudia ^b   Bartolozzi, Carlo ^b   Falaschi, Fabio ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

MR; MR cholangio pancreatography; Pancreatic ducts; Pancreatic hyperenzymemia; Secretin

Indexed keywords

MAGNETIC RESONANCE IMAGING; NONINVASIVE MEDICAL PROCEDURES;

ASYMPTOMATIC PATIENTS; FUNCTIONAL INFORMATION; INTRAVENOUS INJECTIONS; MR CHOLANGIO-PANCREATOGRAPHY; NON-INVASIVE DIAGNOSTICS; PANCREATIC DUCTS; PANCREATIC HYPERENZYMEMIA; SECRETIN;

DIAGNOSIS;

FERUMOXSIL; PANCREAS ENZYME; SCOPOLAMINE BUTYL BROMIDE; SECRELUX; SECRETIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; DUODENUM DIVERTICULUM; FEMALE; HUMAN; HYPERAMYLASEMIA; IMAGE QUALITY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PANCREAS CYST; PANCREAS DIVISUM; PRIORITY JOURNAL;

EID: 77955850108     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.11.008     Document Type: Article

References (26)

1. Gullo L. Chronic nonpathological hyperamylasemia of pancreatic origin. Gastroenterology 1996;110:1905-8.
2. Gullo L. Familial pancreatic hyperenzymemia. Pancreas 2000;20:158-60.
3. Frulloni L, Patrizi F, Bernardoni L, Cavallini G. Pancreatic hyperenzymemia: Clinical significance and diagnostic approach. JOP 2005;6:536-51.
4. Gullo L. Benign pancreatic hyperenzymemia. Dig Liv Dis 2007;39:698-702.
5. Soto JA, Barish MA, Yucel EK, Siegenberg D, Terrucci JT, Chuttani R. Magnetic resonance cholangiography: Comparison with endoscopic retrograde cholangiopancreatography. Gastroenterology 1996;110:589-97.
6. Matos C, Metens T, Deviere J, et al. Pancreatic duct: Morphologic and functional evaluation with dynamicMRpancreatography after secretin stimulation. Radiology 1997;203:435-41.
7. Sica GT, Braver J, Cooney MJ, Miller FH, Chai JL, Adams DF. Comparison of endoscopic retrograde cholangiopancreatography with MR cholangiopancreatography in patients with pancreatitis. Radiology 1999;210:605-10.
8. Takehara Y. Fast MR imaging for evaluating the pancreaticobiliary system. Eur J Radiol 1999;29:211-32.
9. VitellasKM,Keogan MT, Spritzer CE,RendonCN.MRcholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique. Radiographics 2000;20:939-57.
10. Sai JK, Suyama M, Kubokawa Y, Watanabe S. Diagnosis of mild chronic pancreatitis (Cambridge classification): Comparative study using secretin injection-magnetic resonance cholangiopancreatography and endoscopic retrograde pancreatography. World J Gastroenterol 2008;14:1218-21.
11. Tamura R, Ishibashi T, Takahashi S. Chronic pancreatitis: MRCP versus ERCP for quantitative caliber measurement and qualitative evaluation. Radiology 2006;238:920-8.
12. Cappeliez O, Delhaye M, Deviere J, et al. Chronic pancreatitis: Evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 2000;215:358-64.
13. Manfredi R, Costamagna G, Brizi MG, et al. Severe chronic pancreatitis versus suspected pancreatic disease: DynamicMRcholangiopancreatography after secretin stimulation. Radiology 2000;214:849-55.
14. Czakó L, Endes J, Takács T, Boda K, Lonovics J. Evaluation of pancreatic exocrine function by means of secretin-enhanced MR cholangiopancreatography. Pancreas 2001;23:323-8.
15. Fukukura Y, Fujiyoshi F, Sasaki M, Nakajo M. Pancreatic duct: Morphologic evaluation with MR cholangiopancreatography after secretin stimulation. Radiology 2002;222:674-80.
16. Hellerhoff KJ, Helmberger IIIrd H, Rosch T, Settles MR, Link TM, Rummeny EJ. DynamicMRpancreatography after secretin administration: Image quality and diagnostic accuracy. AJR 2002;179:121-9.
17. Lee NJ, Kim KW, Kim TK, et al. Secretin-stimulated MRCP: Pictorial review. Abdom Imaging 2006;31:575-81.
18. Czakó L. Diagnosis of early-stage chronic pancreatitis by secretinenhanced magnetic resonance cholangiopancreatography. J Gastroenterol 2007;42:113-7.
19. Mortelé KJ, Wiesner W, Zou KH, Ros PR, Silverman SG. Asymptomatic nonspecific serum hyperamylasemia and hyperlipasemia: Spectrum of MRCP findings and clinical implications. Abdom Imaging 2004;29:109-14.
20. Testoni PA, Mariani A, Curioni S, Giussani A, Masci E. Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia. Am J Gastroenterol 2009;104:1780-6.
21. Stern CD. A historical perspective on the discovery of the accessory duct of the pancreas, the ampulla of Vater and pancreas divisum. Gut 1986;27:203-12.
22. Manfredi R, Costamagna G, Brizi MG, et al. Pancreas divisum and santorinicele: Diagnosis with dynamic MR cholangiopancreatography with secretin stimulation. Radiology 2000;217:403-8.
23. Matos C, Deviere J, Cremer M, Nicaise N, Struyven J, Metens T. Acinar filling during secretin-stimulated MR pancreatography. AJR 1998;171:165-9.
24. Balci NC, Noone T, Akun E, Akinci A, Klor HU. Juxtapapillary diverticulum: Findings on MRI. J Magn Reson Imaging 2003;17:487-92.
25. Laffan TA, Horton KM, Klein AP, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR 2008;191:802-7.
26. Fernandez-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. Incidental pancreatic cysts: Clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003;138:427-33.